Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.
Also called NCT01175473
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 148 participants
- Sponsor
- Registry
-
NCT01175473 -
2009-017666-23
-
- Main results
- Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT01175473. Randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2010-11 (actual). Results posted on 2016-10-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Lixisenatide (AVE0010)
- Intervention (Device)
- Pen auto-injector
- Intervention (Drug)
- Liraglutide
- Intervention (Device)
- Pre-filled pen injector
- Intervention (Drug)
- Metformin
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01175473- Content hash
5aa37e629b78e5742d2da495c957a4a40d062da9783beba82c5a735be7f7e263